tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Technical Analysis

7,669 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is -1.56, suggesting Crispr Therapeutics AG is a Sell.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 56.10, while Crispr Therapeutics AG’s (CRSP) share price is $55.47, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 60.38, while Crispr Therapeutics AG’s (CRSP) share price is $55.47, making it a Sell.

Crispr Therapeutics AG (CRSP) Pivot Points

May 21, 2024, 07:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
53.39
54.01
55.12
55.74
56.85
57.47
58.58
Fibonacci
54.01
54.67
55.08
55.74
56.40
56.81
57.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

May 21, 2024, 07:01 AM
Period
Simple
Exponential
MA5
56.01Sell
55.65Sell
MA10
54.92Buy
55.41Buy
MA20
54.93Buy
56.10Sell
MA50
61.86Sell
60.38Sell
MA100
66.37Sell
62.65Sell
MA200
59.41Sell
59.47Sell
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 55.41, while Crispr Therapeutics AG’s (CRSP) share price is $55.47, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 62.65, while Crispr Therapeutics AG’s (CRSP) share price is $55.47, making it a Sell.
Crispr Therapeutics AG’s (CRSP) stock price is $55.47 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 61.86, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $55.47 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 66.37, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $55.47 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 59.41, creating a Sell signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

May 21, 2024, 07:01 AM
Name
Value
Implied Action
RSI (14)
45.11
Neutral
STOCH (9,6)
58.44
Neutral
STOCHRSI (14)
58.44
Neutral
MACD (12,26)
-1.56
Sell
ADX (14)
18.58
Buy
Williams %R
-45.45
Buy
CCI (14)
26.28
Neutral
ATR (14)
2.78
-
Ultimate Oscillator
36.70
Neutral
ROC
4.68
Buy
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 45.11, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 18.58, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is 26.28, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is 4.68, creating a Buy signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Sell.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 45.11, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is -1.56, which suggests CRSP is a Sell.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 56.01, which suggests CRSP is a Sell.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 54.93, which suggests CRSP is a Buy.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 61.86, which suggests CRSP is a Sell.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 59.41, which suggests CRSP is a Sell.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -45.45, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is 26.28, which suggests CRSP is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis